Mandate

Vinge advises Active Biotech on rights offering

August 05, 2022

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights issue of approximately SEK 55 million.

Vinge advises Active Biotech. Vinge’s team primarily consists of Christian Lindhé, Erik Sjöman, Astrid Isberg and Johanne Örnfeldt Svensson.

Related

Vinge advises Chieftain Capital Management in connection with the investment in Koenigsegg Automotive

Vinge has advised Chieftain Capital Management, Inc. (”Chieftain”), a New York based family office, in its investment in the Swedish megacar manufacturer Koenigsegg Automotive AB (“Koenigsegg”).
October 08, 2024

Vinge advises iBinder Group in connection with the acquisition of Avima AB

Avima AB is a Swedish specialist in project and information management, with expertise in complex projects within construction, real estate and infrastructure.
October 07, 2024

Vinge advises Axcel in connection with the launch of Accru Partners, a new group within accounting, tax, audit and advisory services

Vinge has advised the Nordic private equity firm Axcel in connection with its establishment of Accru Partners, a new group of 22 independent firms in Sweden within accounting, tax, audit and other advisory services.
October 04, 2024